-
XW0Q Cranial Cavity and Brain
-
XW0Q0 Open
-
XW0Q00 Brexanolone
-
XW0Q00 Spesolimab Monoclonal Antibody
-
XW0Q01 Daratumumab and Hyaluronidase-fihj
-
XW0Q01 Eladocagene exuparvovec
-
XW0Q02 Bromelain-enriched Proteolytic Enzyme
-
XW0Q02 Nerinitide
-
XW0Q03 Durvalumab Antineoplastic
-
XW0Q03 Maribavir Anti-infective
-
XW0Q04 Teclistamab Antineoplastic
-
XW0Q05 Mosunetuzumab Antineoplastic
-
XW0Q05 Narsoplimab Monoclonal Antibody
-
XW0Q06 Afamitresgene Autoleucel Immunotherapy
-
XW0Q06 Lefamulin Anti-infective
-
XW0Q06 Terlipressin
-
XW0Q07 Coagulation Factor Xa, Inactivated
-
XW0Q07 Tabelecleucel Immunotherapy
-
XW0Q07 Trilaciclib
-
XW0Q08 Lurbinectedin
-
XW0Q08 Mineral-based Topical Hemostatic Agent
-
XW0Q08 Treosulfan
-
XW0Q08 Uridine Triacetate
-
XW0Q09 Ceftolozane/Tazobactam Anti-infective
-
XW0Q09 Inebilizumab-cdon
-
XW0Q09 Satralizumab-mwge
-
XW0Q0A Cefiderocol Anti-infective
-
XW0Q0A Ciltacabtagene Autoleucel
-
XW0Q0B Amivantamab Monoclonal Antibody
-
XW0Q0B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0Q0B Omadacycline Anti-infective
-
XW0Q0C Eculizumab
-
XW0Q0C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0Q0D Atezolizumab Antineoplastic
-
XW0Q0D Engineered Allogeneic Thymus Tissue
-
XW0Q0E Etesevimab Monoclonal Antibody
-
XW0Q0E Remdesivir Anti-infective
-
XW0Q0F Bamlanivimab Monoclonal Antibody
-
XW0Q0F Other New Technology Therapeutic Substance
-
XW0Q0G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0Q0G Plazomicin Anti-infective
-
XW0Q0G REGN-COV2 Monoclonal Antibody
-
XW0Q0G Sarilumab
-
XW0Q0H Axicabtagene Ciloleucel Immunotherapy
-
XW0Q0H Other New Technology Monoclonal Antibody
-
XW0Q0H Synthetic Human Angiotensin II
-
XW0Q0H Tocilizumab
-
XW0Q0J Apalutamide Antineoplastic
-
XW0Q0J Tisagenlecleucel Immunotherapy
-
XW0Q0K Fosfomycin Anti-infective
-
XW0Q0K Idecabtagene Vicleucel Immunotherapy
-
XW0Q0K Leronlimab Monoclonal Antibody
-
XW0Q0L CD24Fc Immunomodulator
-
XW0Q0L Erdafitinib Antineoplastic
-
XW0Q0L Lifileucel Immunotherapy
-
XW0Q0M Baricitinib
-
XW0Q0M Brexucabtagene Autoleucel Immunotherapy
-
XW0Q0M Esketamine Hydrochloride
-
XW0Q0N Lisocabtagene Maraleucel Immunotherapy
-
XW0Q0N Meropenem-vaborbactam Anti-infective
-
XW0Q0P Antibiotic-eluting Bone Void Filler
-
XW0Q0Q Tagraxofusp-erzs Antineoplastic
-
XW0Q0R Fostamatinib
-
XW0Q0R Venetoclax Antineoplastic
-
XW0Q0S COVID-19 Vaccine Dose 1
-
XW0Q0S Iobenguane I-131 Antineoplastic
-
XW0Q0T COVID-19 Vaccine Dose 2
-
XW0Q0T Ruxolitinib
-
XW0Q0U COVID-19 Vaccine
-
XW0Q0U Imipenem-cilastatin-relebactam Anti-infective
-
XW0Q0V COVID-19 Vaccine Dose 3
-
XW0Q0V Gilteritinib Antineoplastic
-
XW0Q0W Caplacizumab
-
XW0Q0W COVID-19 Vaccine Booster
-
XW0Q0X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0Q0X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0Q0Y Other New Technology Monoclonal Antibody
-
-
XW0Q3 Percutaneous
-
XW0Q30 Brexanolone
-
XW0Q30 Spesolimab Monoclonal Antibody
-
XW0Q31 Daratumumab and Hyaluronidase-fihj
-
XW0Q316Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6
-
-
XW0Q31 Eladocagene exuparvovec
-
XW0Q316Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6
-
-
XW0Q32 Bromelain-enriched Proteolytic Enzyme
-
XW0Q32 Nerinitide
-
XW0Q33 Durvalumab Antineoplastic
-
XW0Q33 Maribavir Anti-infective
-
XW0Q34 Teclistamab Antineoplastic
-
XW0Q35 Mosunetuzumab Antineoplastic
-
XW0Q35 Narsoplimab Monoclonal Antibody
-
XW0Q36 Afamitresgene Autoleucel Immunotherapy
-
XW0Q36 Lefamulin Anti-infective
-
XW0Q36 Terlipressin
-
XW0Q37 Coagulation Factor Xa, Inactivated
-
XW0Q37 Tabelecleucel Immunotherapy
-
XW0Q37 Trilaciclib
-
XW0Q38 Lurbinectedin
-
XW0Q38 Mineral-based Topical Hemostatic Agent
-
XW0Q38 Treosulfan
-
XW0Q38 Uridine Triacetate
-
XW0Q39 Ceftolozane/Tazobactam Anti-infective
-
XW0Q39 Inebilizumab-cdon
-
XW0Q39 Satralizumab-mwge
-
XW0Q3A Cefiderocol Anti-infective
-
XW0Q3A Ciltacabtagene Autoleucel
-
XW0Q3B Amivantamab Monoclonal Antibody
-
XW0Q3B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0Q3B Omadacycline Anti-infective
-
XW0Q3C Eculizumab
-
XW0Q3C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0Q3D Atezolizumab Antineoplastic
-
XW0Q3D Engineered Allogeneic Thymus Tissue
-
XW0Q3E Etesevimab Monoclonal Antibody
-
XW0Q3E Remdesivir Anti-infective
-
XW0Q3F Bamlanivimab Monoclonal Antibody
-
XW0Q3F Other New Technology Therapeutic Substance
-
XW0Q3G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0Q3G Plazomicin Anti-infective
-
XW0Q3G REGN-COV2 Monoclonal Antibody
-
XW0Q3G Sarilumab
-
XW0Q3H Axicabtagene Ciloleucel Immunotherapy
-
XW0Q3H Other New Technology Monoclonal Antibody
-
XW0Q3H Synthetic Human Angiotensin II
-
XW0Q3H Tocilizumab
-
XW0Q3J Apalutamide Antineoplastic
-
XW0Q3J Tisagenlecleucel Immunotherapy
-
XW0Q3K Fosfomycin Anti-infective
-
XW0Q3K Idecabtagene Vicleucel Immunotherapy
-
XW0Q3K Leronlimab Monoclonal Antibody
-
XW0Q3L CD24Fc Immunomodulator
-
XW0Q3L Erdafitinib Antineoplastic
-
XW0Q3L Lifileucel Immunotherapy
-
XW0Q3M Baricitinib
-
XW0Q3M Brexucabtagene Autoleucel Immunotherapy
-
XW0Q3M Esketamine Hydrochloride
-
XW0Q3N Lisocabtagene Maraleucel Immunotherapy
-
XW0Q3N Meropenem-vaborbactam Anti-infective
-
XW0Q3P Antibiotic-eluting Bone Void Filler
-
XW0Q3Q Tagraxofusp-erzs Antineoplastic
-
XW0Q3R Fostamatinib
-
XW0Q3R Venetoclax Antineoplastic
-
XW0Q3S COVID-19 Vaccine Dose 1
-
XW0Q3S Iobenguane I-131 Antineoplastic
-
XW0Q3T COVID-19 Vaccine Dose 2
-
XW0Q3T Ruxolitinib
-
XW0Q3U COVID-19 Vaccine
-
XW0Q3U Imipenem-cilastatin-relebactam Anti-infective
-
XW0Q3V COVID-19 Vaccine Dose 3
-
XW0Q3V Gilteritinib Antineoplastic
-
XW0Q3W Caplacizumab
-
XW0Q3W COVID-19 Vaccine Booster
-
XW0Q3X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0Q3X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0Q3Y Other New Technology Monoclonal Antibody
-
-
XW0Q7 Via Natural or Artificial Opening
-
XW0Q70 Brexanolone
-
XW0Q70 Spesolimab Monoclonal Antibody
-
XW0Q71 Daratumumab and Hyaluronidase-fihj
-
XW0Q71 Eladocagene exuparvovec
-
XW0Q72 Bromelain-enriched Proteolytic Enzyme
-
XW0Q72 Nerinitide
-
XW0Q73 Durvalumab Antineoplastic
-
XW0Q73 Maribavir Anti-infective
-
XW0Q74 Teclistamab Antineoplastic
-
XW0Q75 Mosunetuzumab Antineoplastic
-
XW0Q75 Narsoplimab Monoclonal Antibody
-
XW0Q76 Afamitresgene Autoleucel Immunotherapy
-
XW0Q76 Lefamulin Anti-infective
-
XW0Q76 Terlipressin
-
XW0Q77 Coagulation Factor Xa, Inactivated
-
XW0Q77 Tabelecleucel Immunotherapy
-
XW0Q77 Trilaciclib
-
XW0Q78 Lurbinectedin
-
XW0Q78 Mineral-based Topical Hemostatic Agent
-
XW0Q78 Treosulfan
-
XW0Q78 Uridine Triacetate
-
XW0Q79 Ceftolozane/Tazobactam Anti-infective
-
XW0Q79 Inebilizumab-cdon
-
XW0Q79 Satralizumab-mwge
-
XW0Q7A Cefiderocol Anti-infective
-
XW0Q7A Ciltacabtagene Autoleucel
-
XW0Q7B Amivantamab Monoclonal Antibody
-
XW0Q7B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0Q7B Omadacycline Anti-infective
-
XW0Q7C Eculizumab
-
XW0Q7C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0Q7D Atezolizumab Antineoplastic
-
XW0Q7D Engineered Allogeneic Thymus Tissue
-
XW0Q7E Etesevimab Monoclonal Antibody
-
XW0Q7E Remdesivir Anti-infective
-
XW0Q7F Bamlanivimab Monoclonal Antibody
-
XW0Q7F Other New Technology Therapeutic Substance
-
XW0Q7G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0Q7G Plazomicin Anti-infective
-
XW0Q7G REGN-COV2 Monoclonal Antibody
-
XW0Q7G Sarilumab
-
XW0Q7H Axicabtagene Ciloleucel Immunotherapy
-
XW0Q7H Other New Technology Monoclonal Antibody
-
XW0Q7H Synthetic Human Angiotensin II
-
XW0Q7H Tocilizumab
-
XW0Q7J Apalutamide Antineoplastic
-
XW0Q7J Tisagenlecleucel Immunotherapy
-
XW0Q7K Fosfomycin Anti-infective
-
XW0Q7K Idecabtagene Vicleucel Immunotherapy
-
XW0Q7K Leronlimab Monoclonal Antibody
-
XW0Q7L CD24Fc Immunomodulator
-
XW0Q7L Erdafitinib Antineoplastic
-
XW0Q7L Lifileucel Immunotherapy
-
XW0Q7M Baricitinib
-
XW0Q7M Brexucabtagene Autoleucel Immunotherapy
-
XW0Q7M Esketamine Hydrochloride
-
XW0Q7N Lisocabtagene Maraleucel Immunotherapy
-
XW0Q7N Meropenem-vaborbactam Anti-infective
-
XW0Q7P Antibiotic-eluting Bone Void Filler
-
XW0Q7Q Tagraxofusp-erzs Antineoplastic
-
XW0Q7R Fostamatinib
-
XW0Q7R Venetoclax Antineoplastic
-
XW0Q7S COVID-19 Vaccine Dose 1
-
XW0Q7S Iobenguane I-131 Antineoplastic
-
XW0Q7T COVID-19 Vaccine Dose 2
-
XW0Q7T Ruxolitinib
-
XW0Q7U COVID-19 Vaccine
-
XW0Q7U Imipenem-cilastatin-relebactam Anti-infective
-
XW0Q7V COVID-19 Vaccine Dose 3
-
XW0Q7V Gilteritinib Antineoplastic
-
XW0Q7W Caplacizumab
-
XW0Q7W COVID-19 Vaccine Booster
-
XW0Q7X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0Q7X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0Q7Y Other New Technology Monoclonal Antibody
-
-
XW0Q8 Via Natural or Artificial Opening Endoscopic
-
XW0Q80 Brexanolone
-
XW0Q80 Spesolimab Monoclonal Antibody
-
XW0Q81 Daratumumab and Hyaluronidase-fihj
-
XW0Q81 Eladocagene exuparvovec
-
XW0Q82 Bromelain-enriched Proteolytic Enzyme
-
XW0Q82 Nerinitide
-
XW0Q83 Durvalumab Antineoplastic
-
XW0Q83 Maribavir Anti-infective
-
XW0Q84 Teclistamab Antineoplastic
-
XW0Q85 Mosunetuzumab Antineoplastic
-
XW0Q85 Narsoplimab Monoclonal Antibody
-
XW0Q86 Afamitresgene Autoleucel Immunotherapy
-
XW0Q86 Lefamulin Anti-infective
-
XW0Q86 Terlipressin
-
XW0Q87 Coagulation Factor Xa, Inactivated
-
XW0Q87 Tabelecleucel Immunotherapy
-
XW0Q87 Trilaciclib
-
XW0Q88 Lurbinectedin
-
XW0Q88 Mineral-based Topical Hemostatic Agent
-
XW0Q88 Treosulfan
-
XW0Q88 Uridine Triacetate
-
XW0Q89 Ceftolozane/Tazobactam Anti-infective
-
XW0Q89 Inebilizumab-cdon
-
XW0Q89 Satralizumab-mwge
-
XW0Q8A Cefiderocol Anti-infective
-
XW0Q8A Ciltacabtagene Autoleucel
-
XW0Q8B Amivantamab Monoclonal Antibody
-
XW0Q8B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0Q8B Omadacycline Anti-infective
-
XW0Q8C Eculizumab
-
XW0Q8C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0Q8D Atezolizumab Antineoplastic
-
XW0Q8D Engineered Allogeneic Thymus Tissue
-
XW0Q8E Etesevimab Monoclonal Antibody
-
XW0Q8E Remdesivir Anti-infective
-
XW0Q8F Bamlanivimab Monoclonal Antibody
-
XW0Q8F Other New Technology Therapeutic Substance
-
XW0Q8G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0Q8G Plazomicin Anti-infective
-
XW0Q8G REGN-COV2 Monoclonal Antibody
-
XW0Q8G Sarilumab
-
XW0Q8H Axicabtagene Ciloleucel Immunotherapy
-
XW0Q8H Other New Technology Monoclonal Antibody
-
XW0Q8H Synthetic Human Angiotensin II
-
XW0Q8H Tocilizumab
-
XW0Q8J Apalutamide Antineoplastic
-
XW0Q8J Tisagenlecleucel Immunotherapy
-
XW0Q8K Fosfomycin Anti-infective
-
XW0Q8K Idecabtagene Vicleucel Immunotherapy
-
XW0Q8K Leronlimab Monoclonal Antibody
-
XW0Q8L CD24Fc Immunomodulator
-
XW0Q8L Erdafitinib Antineoplastic
-
XW0Q8L Lifileucel Immunotherapy
-
XW0Q8M Baricitinib
-
XW0Q8M Brexucabtagene Autoleucel Immunotherapy
-
XW0Q8M Esketamine Hydrochloride
-
XW0Q8N Lisocabtagene Maraleucel Immunotherapy
-
XW0Q8N Meropenem-vaborbactam Anti-infective
-
XW0Q8P Antibiotic-eluting Bone Void Filler
-
XW0Q8Q Tagraxofusp-erzs Antineoplastic
-
XW0Q8R Fostamatinib
-
XW0Q8R Venetoclax Antineoplastic
-
XW0Q8S COVID-19 Vaccine Dose 1
-
XW0Q8S Iobenguane I-131 Antineoplastic
-
XW0Q8T COVID-19 Vaccine Dose 2
-
XW0Q8T Ruxolitinib
-
XW0Q8U COVID-19 Vaccine
-
XW0Q8U Imipenem-cilastatin-relebactam Anti-infective
-
XW0Q8V COVID-19 Vaccine Dose 3
-
XW0Q8V Gilteritinib Antineoplastic
-
XW0Q8W Caplacizumab
-
XW0Q8W COVID-19 Vaccine Booster
-
XW0Q8X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0Q8X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0Q8Y Other New Technology Monoclonal Antibody
-
-
XW0QX External
-
XW0QX0 Brexanolone
-
XW0QX0 Spesolimab Monoclonal Antibody
-
XW0QX1 Daratumumab and Hyaluronidase-fihj
-
XW0QX1 Eladocagene exuparvovec
-
XW0QX2 Bromelain-enriched Proteolytic Enzyme
-
XW0QX2 Nerinitide
-
XW0QX3 Durvalumab Antineoplastic
-
XW0QX3 Maribavir Anti-infective
-
XW0QX4 Teclistamab Antineoplastic
-
XW0QX5 Mosunetuzumab Antineoplastic
-
XW0QX5 Narsoplimab Monoclonal Antibody
-
XW0QX6 Afamitresgene Autoleucel Immunotherapy
-
XW0QX6 Lefamulin Anti-infective
-
XW0QX6 Terlipressin
-
XW0QX7 Coagulation Factor Xa, Inactivated
-
XW0QX7 Tabelecleucel Immunotherapy
-
XW0QX7 Trilaciclib
-
XW0QX8 Lurbinectedin
-
XW0QX8 Mineral-based Topical Hemostatic Agent
-
XW0QX8 Treosulfan
-
XW0QX8 Uridine Triacetate
-
XW0QX9 Ceftolozane/Tazobactam Anti-infective
-
XW0QX9 Inebilizumab-cdon
-
XW0QX9 Satralizumab-mwge
-
XW0QXA Cefiderocol Anti-infective
-
XW0QXA Ciltacabtagene Autoleucel
-
XW0QXB Amivantamab Monoclonal Antibody
-
XW0QXB Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW0QXB Omadacycline Anti-infective
-
XW0QXC Eculizumab
-
XW0QXC Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW0QXD Atezolizumab Antineoplastic
-
XW0QXD Engineered Allogeneic Thymus Tissue
-
XW0QXE Etesevimab Monoclonal Antibody
-
XW0QXE Remdesivir Anti-infective
-
XW0QXF Bamlanivimab Monoclonal Antibody
-
XW0QXF Other New Technology Therapeutic Substance
-
XW0QXG Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW0QXG Plazomicin Anti-infective
-
XW0QXG REGN-COV2 Monoclonal Antibody
-
XW0QXG Sarilumab
-
XW0QXH Axicabtagene Ciloleucel Immunotherapy
-
XW0QXH Other New Technology Monoclonal Antibody
-
XW0QXH Synthetic Human Angiotensin II
-
XW0QXH Tocilizumab
-
XW0QXJ Apalutamide Antineoplastic
-
XW0QXJ Tisagenlecleucel Immunotherapy
-
XW0QXK Fosfomycin Anti-infective
-
XW0QXK Idecabtagene Vicleucel Immunotherapy
-
XW0QXK Leronlimab Monoclonal Antibody
-
XW0QXL CD24Fc Immunomodulator
-
XW0QXL Erdafitinib Antineoplastic
-
XW0QXL Lifileucel Immunotherapy
-
XW0QXM Baricitinib
-
XW0QXM Brexucabtagene Autoleucel Immunotherapy
-
XW0QXM Esketamine Hydrochloride
-
XW0QXN Lisocabtagene Maraleucel Immunotherapy
-
XW0QXN Meropenem-vaborbactam Anti-infective
-
XW0QXP Antibiotic-eluting Bone Void Filler
-
XW0QXQ Tagraxofusp-erzs Antineoplastic
-
XW0QXR Fostamatinib
-
XW0QXR Venetoclax Antineoplastic
-
XW0QXS COVID-19 Vaccine Dose 1
-
XW0QXS Iobenguane I-131 Antineoplastic
-
XW0QXT COVID-19 Vaccine Dose 2
-
XW0QXT Ruxolitinib
-
XW0QXU COVID-19 Vaccine
-
XW0QXU Imipenem-cilastatin-relebactam Anti-infective
-
XW0QXV COVID-19 Vaccine Dose 3
-
XW0QXV Gilteritinib Antineoplastic
-
XW0QXW Caplacizumab
-
XW0QXW COVID-19 Vaccine Booster
-
XW0QXX Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW0QXX Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW0QXY Other New Technology Monoclonal Antibody
-
-